The Lancet Diabetes & Endocrinology · 2021 · 178 citations · 28 references
MedicineEndocrinologyImmunologyDiabetologyImmunotherapyInflammationChronic InflammationDiabetes ControlDiabetes ManagementDiabetes MellitusDiabetes PharmacotherapyGlycemic ControlBeta Cell PreservationBeta-cell DysfunctionDiabetes Mellitus ManagementInsulin Secretion EnhancementIslet Cell DysfunctionPancreatic Beta-cell FunctionType 1 Diabetes Pathophysiology
28
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold, Brian N. Bundy, S. Alice Long et al. · New England Journal of Medicine · 2019 · 1.1K citations · Full text